Thomas Des Rosier Seres Therapeutics, Inc. (MCRB) insider trading activity

Thomas Des Rosier is Chief Legal Officer and EVP of Seres Therapeutics, Inc.. Currently has a direct ownership of 142,456 shares of MCRB, which is worth approximately $98,294. The most recent transaction as insider was on Feb 18, 2025, when has been sold 4,300 shares (Common Stock) at a price of $0.81 per share, resulting in proceeds of $3,483. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K

5.37% 3M change

18.15% 12M change

Total Value Held $98,294

Thomas DesRosier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	SELL Open market or private sale	$3,483 $0.81 p/Share	4,300 Reduced 2.93%	142,456 Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	11,564 Added 7.3%	146,756 Common Stock
Nov 18 2024	SELL Open market or private sale	$474 $0.54 p/Share	878 Reduced 0.65%	135,192 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	2,656 Added 1.91%	136,070 Common Stock
Oct 28 2024	SELL Open market or private sale	$2,938 $0.69 p/Share	4,259 Reduced 3.09%	133,414 Common Stock
Oct 27 2024	BUY Exercise of conversion of derivative security	-	13,500 Added 8.93%	137,673 Common Stock
Aug 16 2024	SELL Open market or private sale	$733 $0.84 p/Share	873 Reduced 0.7%	124,173 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	2,656 Added 2.08%	125,046 Common Stock
May 15 2024	SELL Open market or private sale	$792 $0.94 p/Share	843 Reduced 0.68%	122,390 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	2,656 Added 2.11%	123,233 Common Stock
Feb 16 2024	SELL Open market or private sale	$4,254 $1.08 p/Share	3,939 Reduced 3.16%	120,577 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	-	10,625 Added 7.86%	124,516 Common Stock
Oct 30 2023	SELL Open market or private sale	$5,610 $1.35 p/Share	4,156 Reduced 3.52%	113,891 Common Stock
Oct 27 2023	BUY Exercise of conversion of derivative security	-	13,501 Added 10.26%	118,047 Common Stock
Jul 05 2022	BUY Grant, award, or other acquisition	$200,000 $3.15 p/Share	63,492 Added 37.78%	104,546 Common Stock

Thomas Des Rosier

Chief Legal Officer and EVP

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MCRB shares.

Notify only if

Value

Insider Trading

Get notified when an Seres Therapeutics, Inc. insider buys or sells MCRB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Seres Therapeutics, Inc.

Track Activities on MCRB

Account